
CRISPR Startup Caribou Biosciences Raises $30m Series B as Gene Editing for Ag Picks up Pace
In agriculture, Caribou Biosciences is researching the use of CRISPR to promote drought tolerance, disease resistance, increase crop yields, and develop healthier crops.
Sponsored
Here’s where AI could make the biggest impact in the agrifoodtech sector